Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05599360
Title Vyxeos for Induction of Low- or Intermediate-risk.
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Shaare Zedek Medical Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries ISR